Reddy-Dasatinib 50 mg (Dasatinib (Dasatinib (S)-Propylene Glycol) TABLET) 50 MG

REDDY-DASATINIB 50 MG tablets contain dasatinib, a medication used to treat certain types of cancer. This oral tablet is manufactured by Dr. Reddy's Laboratories Ltd. and is designed for targeted therapy.

Strength

50 MG

Manufacturer / TM Owner

DR REDDY'S LABORATORIES LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REDDY-DASATINIB 50 MG tablets are primarily used in the treatment of specific types of cancer. Dasatinib is often prescribed for conditions where targeted therapy is beneficial. Patients may wonder, 'What is dasatinib used for?' This medication is typically used to inhibit the growth of cancer cells by interfering with their ability to divide and spread.

Side Effects

Common effects of REDDY-DASATINIB 50 MG tablets may include fatigue, nausea, and skin rashes. Some users might experience appetite changes or mild gastrointestinal discomfort. These effects can vary from person to person and are not exhaustive.

Precautions & Warnings

REDDY-DASATINIB 50 MG tablets should be handled with care. It is important to follow the advice of a healthcare professional regarding storage and administration. Patients should be aware of potential interactions and discuss any existing medical conditions with their healthcare provider.

Avoid Interactions

REDDY-DASATINIB 50 MG tablets may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided unless advised otherwise by a healthcare professional.

Frequently Asked Questions

REDDY-DASATINIB 50 MG tablets are used in the treatment of certain types of cancer, targeting the growth of cancer cells.

Store REDDY-DASATINIB 50 MG tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Common side effects may include fatigue, nausea, skin rashes, and appetite changes. Always consult a healthcare professional for personalized advice.

REDDY-DASATINIB 50 MG may interact with other medications, especially those that affect liver enzymes. Always consult a healthcare professional before combining medications.

The safety of REDDY-DASATINIB 50 MG for long-term use should be discussed with a healthcare professional, who can provide guidance based on individual health conditions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.